Product Information
TRIAZOLAM 0.125 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3397 per EA under NDC 70710152101. Its NADAC has been published 159 times since Jun 14, 2023.
Strength
.125 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710152101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA213003On Market Since
12/30/2022
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.125 MG TABLET has been published 159 times since Jun 14, 2023, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3397 per EA |
|---|---|
| All-time high | $0.9502 (Aug 16, 2023) |
| All-time low | $0.2219 (Jan 22, 2025) |
| 52-week high | $0.3975 |
| 52-week low | $0.3206 |
| Median price | $0.3652 |
| Average price | $0.4601 |
| Largest weekly change | -44.0% (Feb 21, 2024) |
| Weeks tracked | 159 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.125 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3397 per EA (NDC 70710152101), effective Jun 24, 2026.
How has the price of TRIAZOLAM 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.125 MG TABLET has declined 61.1%. It has been tracked across 159 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.125 MG TABLET?
Since Jun 14, 2023, the NADAC for TRIAZOLAM 0.125 MG TABLET has ranged from a low of $0.2219 (Jan 22, 2025) to a high of $0.9502 (Aug 16, 2023), with a median of $0.3652 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.125 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRIAZOLAM 0.125 MG TABLET, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.125 MG TABLET?
TRIAZOLAM 0.125 MG TABLET (NDC 70710152101) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification